EBF2 and cancer: The authors reported that the ZAG factor, highly expressed in several types of cancers[96-98], could induce the activation of PPARγ and early B cell factor 2 (EBF2) and the recruitment of these factors to the PRDM16 promoter and consequently increase the levels of UCP1 protein[95].